Cost-Effectiveness Of Delayed-Release Dimethyl Fumarate Compared To Glatiramer Acetate And Fingolimod For The Treatment Of Relapsing-Remitting Multiple Sclerosis
May 1, 2014, 00:00
10.1016/j.jval.2014.03.356
https://www.valueinhealthjournal.com/article/S1098-3015(14)00407-0/fulltext
Title :
Cost-Effectiveness Of Delayed-Release Dimethyl Fumarate Compared To Glatiramer Acetate And Fingolimod For The Treatment Of Relapsing-Remitting Multiple Sclerosis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00407-0&doi=10.1016/j.jval.2014.03.356
First page :
A60
Section Title :
Neurological Disorders
Open access? :
No
Section Order :
1397